Bending, Not Breaking: HDA President Chip Davis On Rx Distribution During COVID
Executive Summary
Rollout of a coronavirus vaccine offers chance to demonstrate distribution system’s value to policymakers, and Davis knows that could impact the trajectory of issues such as track and trace that will return to prominence after the pandemic eases.
You may also be interested in...
Supply Chain Conversations Should Continue, But Industry Wants More Government Transparency
Healthcare Distribution Alliance CEO Chip Davis says drug wholesalers and suppliers need the government’s information on product demand, just as the government needs industry inventory data, to anticipate and avert shortages.
New Biosimilars Council Head Seeks Insulin Lessons As More Biosimilar Launches Loom
Craig Burton, who replaces the FDLI-bound Christine Simmon, tells the Pink Sheet that fighting rebating practices which harm insulin patients now can pave the way for successful launches of Humira biosimilars next year. Biosimilar markets should not be ‘winner-take-all,’ he says.
New AAM CEO: Traditional Lobbying On Lowering Health Care Costs Can Mix With COVID-19 Talks
Dan Leonard is working on post-pandemic generic drug issues, using coronavirus as a way to get in front of lawmakers.